Pulmonary adverse events associated with hypertension in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors

Introduction: Non-small cell lung cancer patients have gained therapeutic benefits from immune checkpoint inhibitors, although immune-related adverse events (irAEs) could be inevitable. Whether irAEs are associated with chronic diseases is still unclear, our study aims to clarify the distinct advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianing, Wen, Yaokai, Chu, Xiangling, Liu, Yuzhi, Su, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468816/
https://www.ncbi.nlm.nih.gov/pubmed/36110543
http://dx.doi.org/10.3389/fphar.2022.944342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468816/
https://www.ncbi.nlm.nih.gov/pubmed/36110543
http://dx.doi.org/10.3389/fphar.2022.944342

Ejemplares similares